share_log

T2 Biosystems | EFFECT: Others

T2 Biosystems | EFFECT: Others

T2 Biosystems | EFFECT：其他
美股sec公告 ·  06/05 18:06
牛牛AI助理已提取核心訊息
T2 Biosystems, a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on June 3, 2024. The notice, bearing the Accession Number 0001213900-24-046256, indicates that the company's submission of form POS AM has been officially accepted and is now effective. The SEC's approval is a significant regulatory milestone for T2 Biosystems, which is identified by the CIK number 0001885408 and had previously filed under the number 333-262835.
T2 Biosystems, a company listed in the United States, has received a Notice of Effectiveness from the Securities and Exchange Commission (SEC) on June 3, 2024. The notice, bearing the Accession Number 0001213900-24-046256, indicates that the company's submission of form POS AM has been officially accepted and is now effective. The SEC's approval is a significant regulatory milestone for T2 Biosystems, which is identified by the CIK number 0001885408 and had previously filed under the number 333-262835.
美國上市公司t2 biosystems於2024年6月3日收到證券交易委員會（SEC）的有效通知，該通知軸承存取號碼0001213900-24-046256，顯示該公司提交的表格pos am已經正式被接受並生效。SEC的批准是t2 biosystems的重要監管里程碑，其CIK編號為0001885408，之前已申請333-262835號。
美國上市公司t2 biosystems於2024年6月3日收到證券交易委員會（SEC）的有效通知，該通知軸承存取號碼0001213900-24-046256，顯示該公司提交的表格pos am已經正式被接受並生效。SEC的批准是t2 biosystems的重要監管里程碑，其CIK編號為0001885408，之前已申請333-262835號。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。